Opening the aperture: taking a wider view of the inhalables market

With a new company strategy in place and a combined focus on both drug and device development, Dr Kevin Robinson spoke to Vectura’s new CEO and Executive Director, Will Downie, about the current and future market for inhaled therapies

picture of

Breaking News

Positive update on the development of new XF‐platform drug formulations

Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for ...

Caldic Benelux adds third cleanroom to expand filling services

The Belgian pharmaceutical services company has recently invested in a third cleanroom to expand filling of flammable ...

Alcami acquires TriPharm Services

US-based Alcami has acquired a new sterile fill-finish company near the Research Triangle Park in North Carolina

The Lonza powder-in-capsule microdosing approach

Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...

Datwyler launches spray-coated plungers to minimise leachables

Datwyler has launched its NeoFlex plungers to help developers better protect the integrity of injectable formulations ...

SCHOTT extends syringe format for sensitive biologics

Materials specialist SCHOTT has extended its syriQ BioPure syringe format to enable optimised administration of highly ...

Sustainability and innovation in the complex combination therapy sector

The patient and commercial benefits of bringing new drugs to market in the shortest possible time are well recognised; ...

Aptar and Lupin to launch India’s first smart device for metered-dose inhalers

ADHERO is designed to help patients with chronic respiratory diseases track their MDI usage

Newly approved nasal spray chooses Aptar Pharma delivery system

The company that makes a newly approved epilepsy nasal spray has chosen Unidose Liquid System as its delivery device

The importance of instrumentation and data acquisition on a research-scale tablet press

In this article, Robert Sedlock of Natoli ­Engineering discusses the value that an instrumented tablet press can ...

Granulation: an established technology in a changing world

Optimising the granulation process — the most important unit operation during the production of pharmaceutical oral ...

CPhI Worldwide: Market conditions bode well for global pharma in 2020

Value-added medicines, preventive drugs, early diagnostics and patient experience are some of the trends for the year ...

Boehringer chooses PhoreMost for new drug discovery collaboration

PhoreMost's Siteseeker platform will be deployed to identify novel targets for Boehringer’s programmes

Fujifilm builds first liposome production facility in Japan

Designed to comply with GMP standards for Japan, the US, and Europe, the facility intends to supply liposome globally